Skip to main content
Clinical Trials/CTRI/2018/07/015048
CTRI/2018/07/015048
Completed
Phase 3

A randomised controlled trial to compare two different doses of maternal B12 supplementation in improving infant B12 deficiency and neurodevelopment - MATCOBIND

Department of Biotechnology0 sites708 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Biotechnology
Enrollment
708
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 3, 2020
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Biotechnology

Eligibility Criteria

Inclusion Criteria

  • Pregnant women
  • \<12 weeks gestation
  • Vegetarian mothers

Exclusion Criteria

  • Elderly primi mother ( \>35 years)
  • 1\. Mothers already on B12 supplementation
  • 2\. Women with multiple gestation, those diagnosed with chronic medical conditions (diabetes mellitus, hypertension, heart disease, neurological disease or thyroid disease), and those who tested
  • positive for hepatitis B, HIV or syphilis (associated with prematurity, IUGR and other neonatal morbidities which could influence neurodevelopment)
  • 1\. Women who anticipate moving out of the city before/ after delivery 2\. Women treated for infertility
  • 3\. Women with known psychological illnesses including depression

Outcomes

Primary Outcomes

Not specified

Similar Trials